ArticleCancer medicine2021

Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.

Peter W Szlosarek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.